Markers of Infection-Mediated Cardiac Damage in Influenza and COVID-19.

Francesco Robert BurkertLukas LanserAlex PizziniRosa Bellmann-Weiler Guenter Weiss

Published in: Pathogens (Basel, Switzerland) (2022)

Our study shows that increased cardiac biomarkers are associated with higher mortality and ICU admission in both, influenza and SARS-CoV-2-infected patients. Cardiac biomarkers are higher in the influenza cohort; however, this does not translate into worse outcomes when compared with the COVID-19 cohort.

Keyphrases

sars cov
coronavirus disease
left ventricular
respiratory syndrome coronavirus
emergency department
intensive care unit
cardiovascular disease
cardiovascular events
heart failure
metabolic syndrome
coronary artery disease
skeletal muscle